Leptomeningeal contrast enhancement and blood-CSF barrier dysfunction in aseptic meningitis

Angelika Alonso1, Philipp Eisele1, Anne D Ebert1

  • 1Department of Neurology (A.A., P.E., A.D.E., M.G., K.S., M.G.H., A.G.), Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany; and Theodor Kocher Institute (B.E.), University of Bern, Bern, Switzerland.

Abstract

Insights

MRI can assess blood-CSF barrier (BCSFB) dysfunction in aseptic meningitis. Leptomeningeal contrast enhancement on MRI correlates with BCSFB leakiness, aiding diagnosis and predicting recovery.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimmunology

Background:

  • Aseptic meningitis can cause blood-CSF barrier (BCSFB) dysfunction.
  • Assessing BCSFB integrity is crucial for managing aseptic meningitis.

Purpose of the Study:

  • To investigate BCSFB dysfunction in aseptic meningitis using MRI.
  • To correlate MRI findings with cerebrospinal fluid (CSF) markers of barrier integrity.

Main Methods:

  • Case series of 14 patients with acute aseptic meningitis.
  • Comparison of MRI characteristics with CSF/serum albumin ratio (Qalb).
  • Analysis of postcontrast fluid-attenuated inversion recovery (FLAIR) MRI for leptomeningeal enhancement.

Main Results:

  • Leptomeningeal contrast enhancement on MRI was observed in patients with moderate to severe BCSFB dysfunction (p = 0.001).
  • Qalb positively correlated with leptomeningeal enhancement on MRI (p = 0.003).
  • Greater BCSFB dysfunction was linked to slower recovery and longer hospital stays.

Conclusions:

  • Postcontrast FLAIR MRI can estimate the severity of meningeal blood-brain barrier (BBB) disturbance.
  • MRI findings may hold diagnostic value for aseptic meningitis patients.
  • MRI offers a non-invasive method to assess BCSFB integrity.